Mirapharm 22
NDC Package 61065-2001-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mirapharm 22 is a medication used as Stimulant. Marketed by Mirapharm., Inc., this product is identified by NDC 61065-2001.

Identification & Billing

NDC Package Code
61065-2001-1
Package Description
1 BOTTLE in 1 BOX / 90 CAPSULE in 1 BOTTLE
Product Code
61065-2001
11-Digit Billing Format
61065200101

Clinical Specifications

Proprietary Name
Mirapharm 22
Dosage Form
-
Usage Information
This product is used as Stimulant. To help the treatment of incurable diseases, various cancer, symptoms of atopy as immunomodulator due to immune deficiency.

Regulatory & Marketing

Labeler Name
Mirapharm., Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
02-06-2015
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61065-2001-1 identifies a specific commercial package of 1 bottle in 1 box / 90 capsule in 1 bottle of Mirapharm 22, labeled by Mirapharm., Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mirapharm., Inc. on February 06, 2015. The current certification is valid through December 31, 2024.

How is this Mirapharm., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61065200101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
61065-2001-1
11-Digit CMS (5-4-2)
61065-2001-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.